Home / We're labelled as a "global niche leader"

We're labelled as a "global niche leader"

We're labelled as a "global niche leader" by Inflexion's Ben Long in his interview with Generics Bulletin about the recent successful acquisition. Combining expertise with clear focus helps solidify Rosemont's future discussed in this piece. Read the interview here.

#Pharma #PharmaceuticalIndustry #Medicines #Generics #Investment

< Return to our latest news